<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McElvaney</surname>
    <given-names>N. G.</given-names>
   </name>
   <name>
    <surname>Burdon</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Holmes</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Glanville</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wark</surname>
    <given-names>P. A. B.</given-names>
   </name>
   <name>
    <surname>Thompson</surname>
    <given-names>P. J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)</article-title>. 
  <source>Lancet Respir. Med.</source>
  <volume>5</volume>, 
  <fpage>51</fpage>–
  <lpage>60</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2213-2600(16)30430-1</pub-id>
  <pub-id pub-id-type="pmid">27916480</pub-id>
 </mixed-citation>
</ref>
